Jane Street
ONC

Jane Street’s BeOne Medicines Ltd ONC Stock Holding History

Jane Street’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Sell
1,900
-16,500
-90% -$4.86M ﹤0.01% 7828
2026
Q1 		$5.46M Buy
18,400
+10,700
+139% +$3.46M ﹤0.01% 3377
2025
Q4 		$2.34M Sell
7,700
-11,700
-60% -$3.83M ﹤0.01% 4499
2025
Q3 		$6.61M Buy
19,400
+1,400
+8% +$425K ﹤0.01% 2993
2025
Q2 		$4.36M Buy
18,000
+800
+5% +$196K ﹤0.01% 3189
2025
Q1 		$4.68M Buy
17,200
+1,300
+8% +$304K ﹤0.01% 3033
2024
Q4 		$2.94M Buy
15,900
+6,400
+67% +$1.31M ﹤0.01% 3488
2024
Q3 		$2.13M Buy
9,500
+7,300
+332% +$1.31M ﹤0.01% 4352
2024
Q2 		$314K Sell
2,200
-5,300
-71% -$817K ﹤0.01% 7730
2024
Q1 		$1.17M Sell
7,500
-800
-10% -$129K ﹤0.01% 5110
2023
Q4 		$1.5M Buy
8,300
+2,500
+43% +$452K ﹤0.01% 4824
2023
Q3 		$1.04M Buy
5,800
+2,000
+53% +$396K ﹤0.01% 5121
2023
Q2 		$678K Sell
3,800
-100
-3% -$23K ﹤0.01% 5843
2023
Q1 		$841K Sell
3,900
-13,300
-77% -$3.19M ﹤0.01% 5343
2022
Q4 		$3.78M Buy
+17,200
New +$3.15M ﹤0.01% 2867
2022
Q3 		– Sell
-1,900
Closed -$308K – 10639
2022
Q2 		$308K Sell
1,900
-6,200
-77% -$968K ﹤0.01% 7573
2022
Q1 		$1.53M Buy
8,100
+5,000
+161% +$1.06M ﹤0.01% 5263
2021
Q4 		$840K Sell
3,100
-6,200
-67% -$2.09M ﹤0.01% 6257
2021
Q3 		$3.38M Buy
+9,300
New +$3.04M ﹤0.01% 3436
2021
Q2 		– Sell
-12,500
Closed -$4.35M – 10545
2021
Q1 		$4.35M Sell
12,500
-3,200
-20% -$1.06M ﹤0.01% 2607
2020
Q4 		$4.06M Buy
15,700
+13,900
+772% +$3.83M ﹤0.01% 2394
2020
Q3 		$516K Buy
+1,800
New +$423K ﹤0.01% 5103
2020
Q1 		– Sell
-7,600
Closed -$1.26M – 6122
2019
Q4 		$1.26M Buy
+7,600
New +$1.26M ﹤0.01% 2478

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's ONC Position: Q2 2026 in Review

Jane Street reduced its BeOne Medicines Ltd (ONC) stake by 88% in Q2 2026, selling an estimated $19.6M and leaving 9,442 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #4665.

Jane Street first reported a position in ONC in Q3 2017 and has held it in 26 quarters since. The position peaked at $24.4M in Q1 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Jane Street held 9,442 shares of BeOne Medicines Ltd worth $2.69M as of Q2 2026.
  • Jane Street sold 66,511 BeOne Medicines Ltd shares in Q2 2026, an estimated $19.6M.
  • BeOne Medicines Ltd made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4665 holding.
  • Jane Street first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 26 quarters since.
  • Jane Street's BeOne Medicines Ltd position peaked at $24.4M in Q1 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.